C12H20N4O6S
348.38 g/mol
医药原料药警告
Relebactam
CAS1174018-99-5
用途分类
医药原料药
化合物类别
杂环
主要用途
医药原料
Relebactam is a diazabicyclooctane beta-lactamase inhibitor, structurally similar to avibactam, and serves as an active pharmaceutical ingredient used in combination with imipenem and cilastatin. It features a piperidine ring that imparts a positive charge, reducing bacterial export, and was approved by the FDA in 2019 as part of the Recarbrio® combination product for treating complicated urinary tract infections, pyelonephritis, and complicated intra-abdominal infections in adults.
active pharmaceutical ingredient in beta-lactamase inhibitor combinationscomponent of combination therapy with imipenem and cilastatin
内容范围: 本页信息面向化学品识别与工业供应、研发、生产场景，不构成疗效宣称、医疗建议或药品使用指导。
相关化合物
强相关同母体
Relebactam
CAS1174020-13-3
医药原料
用途相关同类用途
Potassium clavulanate
CAS61177-45-5
医药原料
参考同类别
Cefditoren pivoxil
CAS117467-28-4
医药原料
参考同类别
Calcium dobesilate monohydrate
CAS117552-78-0
医药原料
参考同类别
Desethanol Dipyridamole
CAS1176886-12-6
医药原料
参考同类别
Desosaminylazithromycin
CAS117693-41-1
医药原料
参考same scaffold
1,1-Dimethylethyl 4-[[[(1R,2S,5R)-6-hydroxy-7-oxo-1,6-diazabicyclo[3.2.1]oct-2-yl]carbonyl]amino]-1-piperidinecarboxylate
CAS1174020-64-4
研究用化合物
安全参考
警告
H373May cause damage to organs through prolonged or repeated exposure
H412Harmful to aquatic life with long lasting effects
海关税则归类
Relebactam(CAS 1174018-99-5)的国际 HS 编码为 2933.39。
HS 编码(国际通用,6 位)
2933.39
欧盟 CN 编码(8 位)
2933 39 99
归类依据欧盟海关化学品目录 ECICS(2026-07 快照,HS 2022 版)。各国税则细目及产品形态可能影响最终归类。
标识符
IUPAC 名称
[(2S,5R)-7-oxo-2-(piperidin-4-ylcarbamoyl)-1,6-diazabicyclo[3.2.1]octan-6-yl] hydrogen sulfate
InChIKey
SMOBCLHAZXOKDQ-ZJUUUORDSA-N
SMILES
C1C[C@H](N2C[C@@H]1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3
别名列表 (19)
- (-)-relebactam monohydrate
- MK-7655 MONOHYDRATE
- MK-7655A COMPONENT RELEBACTAM
- Relebactam
- Relebactam (Standard)
- Relebactam anhydrous
- US8487073, 1A
- relebactamum